Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Reproductive factors, hormones and colorectal cancer-still unresolved.

Rennert G.

Br J Cancer. 2017 Jan 3;116(1):1-3. doi: 10.1038/bjc.2016.388. No abstract available.

PMID:
27898659
2.

Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women.

Tillmans LS, Vierkant RA, Wang AH, Samadder NJ, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):713-9. doi: 10.1158/1055-9965.EPI-14-0756.

3.

Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.

Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Lightfoot S, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2013 Dec;6(12):1251-61. doi: 10.1158/1940-6207.CAPR-13-0249.

4.

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu DS, Chang FW, Chen SP, Hsu RJ.

PLoS One. 2013;8(2):e56667. doi: 10.1371/journal.pone.0056667.

5.
6.

MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.

Fang YJ, Pan ZZ, Li LR, Lu ZH, Zhang LY, Wan DS.

J Exp Clin Cancer Res. 2009 Sep 29;28:132. doi: 10.1186/1756-9966-28-132.

7.

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.

Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT; Women's Health Initiative Investigators..

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2609-18. doi: 10.1158/1055-9965.EPI-08-0385.

8.

Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion.

Smith A, Contreras C, Ko KH, Chow J, Dong X, Tuo B, Zhang HH, Chen DB, Dong H.

Endocrinology. 2008 Sep;149(9):4554-66. doi: 10.1210/en.2007-1597.

9.

Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.

Shen LZ, Hua YB, Yu XM, Xu Q, Chen T, Wang JH, Wu WX.

World J Gastroenterol. 2005 Feb 21;11(7):1060-4.

10.

Expression of estrogen receptor beta in human colorectal cancer.

Xie LQ, Yu JP, Luo HS.

World J Gastroenterol. 2004 Jan 15;10(2):214-7.

11.

Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

Speirs V, Skliris GP, Burdall SE, Carder PJ.

J Clin Pathol. 2002 May;55(5):371-4.

Items per page

Supplemental Content

Support Center